Axovant’s experimental drug for dementia with Lewy bodies failed in trial

Unfortunately one of the few experimental drugs being studied in dementia with Lewy bodies (DLB) has failed. The drug is known as intepirdine. The manufacturer is Axovant. Here’s a link to a short news article from this morning:

www.statnews.com/2018/01/08/alzheimers-axovant-intepirdine/

BIOTECH
A new Alzheimer’s drug, once worth billions, is headed for the trash
By Damian Garde
January 8, 2018
Statnews

Robin